Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Paclitaxel and Concurrent Radiation in Stage II/III Breast Cancer
NCT00647218Phase 2Completed
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Start
- Feb 2000
- Primary completion
- Nov 2004
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection in breast cancer, sponsored by Vanderbilt-Ingram Cancer Center. Started Feb 2000; status: completed.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00647218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00647218.